Migdal Insurance & Financial Holdings’s Redhill Biopharma RDHL Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-568	Closed	-$4.16M	–	658
2021 Q1	$4.16M	Sell	568 -322	-36%	-$2.7M	0.04%	160
2020 Q4	$7.19M	Hold	890	–	–	0.09%	115
2020 Q3	$9.1M	Hold	890	–	–	0.13%	117
2020 Q2	$5.96M	Hold	890	–	–	0.1%	117
2020 Q1	$4.03M	Buy	890 +500	+128%	+$2.5M	0.09%	100
2019 Q4	$2.37M	Hold	390	–	–	0.05%	131
2019 Q3	$2.75M	Hold	390	–	–	0.06%	126
2019 Q2	$2.53M	Hold	390	–	–	0.06%	119
2019 Q1	$3.24M	Hold	390	–	–	0.08%	119
2018 Q4	$2.16M	Hold	390	–	–	0.05%	127
2018 Q3	$3.44M	Sell	390 -6	-2%	-$48.9K	0.07%	179
2018 Q2	$3.38M	Sell	396 -1	-0.3%	-$6.36K	0.08%	168
2018 Q1	$2.05M	Hold	397	–	–	0.05%	178
2017 Q4	$2.04M	Hold	397	–	–	0.05%	165
2017 Q3	$4.3M	Sell	397 -1	-0.3%	-$8.89K	0.1%	138
2017 Q2	$3.43M	Hold	398	–	–	0.08%	119
2017 Q1	$3.82M	Buy	398 +7	+2%	+$69.9K	0.09%	111
2016 Q4	$4.09M	Buy	+391	New	+$4.69M	0.1%	92

Other funds holding RDHL

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $153M AUM

Migdal Insurance & Financial Holdings's RDHL Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Redhill Biopharma (RDHL) in Q2 2021, closing a stake of 568 shares — an estimated $4.16M sold.

Migdal Insurance & Financial Holdings first reported a position in RDHL in Q4 2016 and held it in 18 quarters. The position peaked at $9.1M in Q3 2020. 48 funds tracked by Wall St. Rank hold RDHL as of Q2 2021.

Migdal Insurance & Financial Holdings reported no remaining Redhill Biopharma position as of Q2 2021 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 568 Redhill Biopharma shares in Q2 2021, an estimated $4.16M.
Migdal Insurance & Financial Holdings first reported a position in Redhill Biopharma in Q4 2016 and held it in 18 quarters.
Migdal Insurance & Financial Holdings's Redhill Biopharma position peaked at $9.1M in Q3 2020.
48 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.